Evidence map›Paper›PMID 42319527›Full record

ArticleJournal of robotic surgery2026

Exploratory activity-based direct cost analysis of robotic platforms in urologic surgery.

Paola Picozzi, Umberto Nocco, Eleonora Bossi, Daniela Gattuso, Chiara Labate, Greta Puleo, Veronica Cimolin

Abstract read
In one paragraph

Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paola PicozziDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Milano, 20133, Italy.
Umberto NoccoClinical Engineering Department of ASST Grande Ospedale Metropolitano Niguarda, Milano, 20162, Italy.
Eleonora BossiOperation Management Department, ASST Grande Ospedale Metropolitano Niguarda, Milano, 20162, Italy.
Daniela GattusoOperation Management Department, ASST Grande Ospedale Metropolitano Niguarda, Milano, 20162, Italy.
Chiara LabateClinical Engineering Department of ASST Grande Ospedale Metropolitano Niguarda, Milano, 20162, Italy.
Greta PuleoClinical Engineering Department of ASST Grande Ospedale Metropolitano Niguarda, Milano, 20162, Italy.
Veronica CimolinDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Milano, 20133, Italy. veronica.cimolin@polimi.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Robotic-assisted surgery has become increasingly widespread across surgical specialties over the last two decades. However, the high costs associated with robotic systems remain a major limitation to their diffusion. Recently introduced robotic platforms aim to increase market competition and potentially reduce procedural costs. This study evaluated the direct in-hospital costs associated with three robotic platforms in urologic surgery. A retrospective single-center cost analysis was conducted on robotic-assisted procedures performed in 2023. A total of 284 robotic-assisted radical prostatectomies (RALP) were included (200 Da Vinci, 77 Hugo™ RAS, and 7 Versius

Indexed as

Costs and Cost AnalysisHospital CostsNephrectomyProstatectomyRobotic Surgical ProceduresUrologic Surgical ProceduresHumansMaleOperative TimeRetrospective StudiesCost-analysisNew robotic surgical platformsRobotic surgeryUrology

Identifiers

PMID42319527
PMCPMC13282244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.